Maria Pina S.
- Country
- Italy
- Department
- SC Ematologia e CTMO - Ospedale Businco
Research Overview
Data & Insights
Has run more than one trial at 0 of 19 partner sites.
Specializations
Hematologic Oncology
This investigator specializes in treating Plasmablastic lymphoma (PBL), with particular emphasis on managing cases that have become resistant to conventional treatments or have relapsed after previous therapies.
- Refractory Blood Cancers
- Lymphoma Treatment
- Advanced Therapy Combinations
The investigator focuses on developing treatment strategies for patients who are either ineligible for transplantation or have experienced disease recurrence following transplant procedures.
Novel Therapeutic Approaches
The investigator explores innovative treatment combinations incorporating targeted therapies and proteasome inhibitors for blood cancer management.
- Combination Therapy Development
- Treatment Resistance Management
- Novel Drug Applications
Their work involves evaluating new therapeutic approaches for patients with limited treatment options.
Treatment Optimization
The investigator's expertise includes developing treatment protocols for relapsed hematologic malignancies, with a focus on optimizing therapeutic outcomes.
- Drug Combination Strategies
- Safety Assessment
- Treatment Response Evaluation
Their research emphasizes improving treatment efficacy for patients with challenging blood cancer presentations.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.